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Is the partial pressure of carbon dioxide in the
blood related to the development of retinopathy of
prematurity?
Balazs Gellen, Neil McIntosh, Janet R McColm, Brian W Fleck
Abstract
Aims—To determine the role of carbon
dioxide in the development of retinopathy
of prematurity (ROP).
Methods—This was a retrospective cohort
study of 25 consecutive infants admitted to
the neonatal unit with continuously re-
corded physiological data. The daily mean
and standard deviation (SD) of transcuta-
neous carbon dioxide partial pressure
(tcPCO2) was compared between infants
who had stage 1 or 2 ROP and stage 3 ROP.
The time spent hypocarbic (<3 kPa)
and/or hypercarbic (>10 kPa and >12 kPa)
was also compared between these groups.
Intermittent arterial carbon dioxide ten-
sion was also measured and compared
with the simultaneous tcPCO2 data.
Results—There were no significant diVer-
ences in carbon dioxide variability or time
spent hypocarbic and/or hypercarbic be-
tween the ROP groups on any day. 86% of
transcutaneous values were within 1.5 kPa
of the simultaneous arterial value.
Conclusion—TcPCO2 measurement can be
a very useful management technique.
However, in this cohort neither variable
blood carbon dioxide tension nor duration
of hypercarbia or hypocarbia in the first 2
weeks of life was associated with the
development or severity of ROP.
(Br J Ophthalmol 2001;85:1044–1045)
Retinopathy of prematurity (ROP) is the most
commonly acquired retinal disease in premature
babies. It is multifactorial, with gestational age1–3
and low birth weight1 4 being the most powerful
predictors of progression to disease. Although
originally it was postulated that high arterial
oxygen levels5 6 were causative, more recently
data have shown that fluctuations in arterial
blood oxygen tension7 are more closely related
to the development and severity of the disease.
Clinical studies investigating carbon dioxide
have shown both hypercarbia8 9 and hypocar-
bia10 11 to correlate with retinopathy. Animal
studies have established a link to hypercarbia,12
but diYcultly in inducing hypocarbia has made
it diYcult to resolve these conflicting data.
The aim of this study was to determine
whether hypercarbia or hypocarbia or the
variability of carbon dioxide in the first 2 weeks
of life in extremely preterm infants were associ-
ated with the development of ROP. A criticism
of the previous clinical studies was that they
used intermittent arterial blood gas analysis to
associate PCO2 with pathology,
8–11 we have
analysed continuous transcutaneous carbon
dioxide data.
Methods
This was a retrospective cohort study of infants
who were admitted to the neonatal intensive
care unit, Edinburgh, between 1996 and 1998.
Inclusion criteria were 14 days of continuous
monitored data of transcutaneous carbon
dioxide, at least stage 1 ROP, and less than
1001 g birth weight or less than 30 weeks ges-
tation.
Infants were divided into two groups, stage 1
or 2 ROP (ROP1,2 group) and stage 3 ROP
(ROP3 group). Stage 3 ROP was defined by
the presence of extraretinal neovascularisation.
A computerised neonatal cot monitoring sys-
tem in routine clinical use recorded physiologi-
cal data including transcutaneous carbon diox-
ide pressure (tcPCO2) from Hewlett Packard
combined oxygen and carbon dioxide probes
and 78344A neonatal monitors. The data were
recorded every second and later stored as a 1
minute average of 60 one second data points.
After removal of obvious artefact due to probe
calibration the mean and standard deviation
were calculated for each day of the first 14 days
of life. For each period we also noted the
number of minutes that the tcPCO2 was under 3
kPa, was over 10 kPa, and was over 12 kPa. All
values were further aggregated over a week or 2
week period to produce a single mean for each
statistic for each baby. Arterial carbon dioxide
(PCO2) tension was also measured intermit-
tently by umbilical or peripheral arterial cath-
eter sample and compared with the simultane-
ous transcutaneous carbon dioxide data.
Retinopathy of prematurity was diagnosed
using binocular indirect ophthalmoscopy with a
speculum and scleral indentation. Careful 360°
examination of the peripheral retina up to the
ora serrata was performed in every instance, by
one of two experienced paediatric ophthalmolo-
gists. The first examination occurred at 4–6
weeks post delivery and was repeated weekly
until the retina was fully vascularised. ROP was
determined using the international classification
for ROP.13 Data from the infants who were in
ROP1,2 group were compared with those who
were in ROP3 group by repeated measures
analysis of variance (SPSS).
For each baby on each day there was a mean
value of tcPCO2 (with artefacts excluded) and a
standard deviation (SD). The SDs were then
averaged as a measure of variability. The daily
means and the daily standard deviations of the
babies in the ROP1,2 and ROP3 groups were
compared on a daily basis by t test and
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throughout the study using a repeated meas-
ures ANOVA (analysis of variance). A Bonfer-
roni correction (with significance defined as p
<0.05) was used because there were a large
number of comparisons for the t test.
The time in minutes that the tcPCO2 was <3
kPa, >10 kPa, and >12 kPa was calculated for
each infant during week 1 and again during
week 2. The values in ROP1,2 group were
compared with ROP3 group using a Student’s
t test.
Results
Over the 2 year period 50 infants were
diagnosed with any stage of ROP and 25 of
these babies met the inclusion criteria, the oth-
ers failing mainly because of a lack of the 2
weeks of continuous monitoring data. Infants
enrolled in the study had a mean birth weight
of 691 g (530–1245 g) and gestational age 25.2
weeks (range 24–29). Ten were in ROP1,2
group and 15 were in ROP3 group.
There was no statistical diVerence between
mean tcPCO2 values or in the variability of
tcPCO2 during the first 14 days of life between
the two groups (Table 1). The length of time
that the tcPCO2 was under 3 kPa, was over 10
kPa, or was over 12 kPa was also not
significantly diVerent between ROP1,2 and
ROP3 group in either the first or the second
week of life.
Figure 1 is a Bland-Altmann plot of the
intermittently measured PaCO2 versus the
simultaneous tcPCO2 data and the diVerences
were not significant; 85.8% of transcutaneous
values were within 1.5 kPa of the simultaneous
arterial value, and a diVerence of <1.5 kPa
between tcPCO2 and PaCO2 was accepted in this
study as a satisfactory agreement.
Discussion
The present study does not support the view
that either increased variability of blood carbon
dioxide or a particular duration of hypercarbia
or hypocarbia in the first 2 weeks of life is
related to the development or severity of ROP.
In this study blood carbon dioxide levels were
measured by a continuous transcutaneous
monitoring system for 14 days which is in
contrast with other studies that have used inter-
mittent blood gas analysis. To ensure that the
transcutaneous measurements were accurate
they were compared with the simultaneous but
intermittently measured arterial carbon dioxide
tension. We found that agreement between the
methods was usually excellent and the compari-
son was clinically highly satisfactory.
The transcutaneous measurements resulted
in nearly 20 000 data points per baby—each of
which in itself was a 1 minute average of 60 one
second points. This allowed an objective analy-
sis of the variability of blood carbon dioxide.
The number of infants enrolled in the study
was small but the confidence intervals of the
results suggest that the lack of diVerence
between groups is unlikely to be related to
small numbers creating a type II error. It would
certainly be preferable to involve more babies,
but during the 2 year period of investigation
only 25 infants met the requirements of the
inclusion criteria.
The known eVects of carbon dioxide tension
on small vessel calibre make it inappropriate to
discard carbon dioxide as an important factor
based on this study alone. Our group has
developed an animal model of ROP based on
clinically relevant fluctuations in oxygen14 15
and we plan to use this to investigate the com-
bination of oxygen variability and hypercarbia
on the development and severity of ROP.
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Figure 1 The comparison of transcutaneous and
simultaneous arterial PCO2. These data are displayed as a
Bland-Altman plot; 85.8% of transcutaneous values being
within 1.5 kPa of the simultaneous arterial value (1.5 kPa
or less diVerence between tcPCO2 and PCO2 was accepted in
this study as a satisfactory agreement.) DiVerence =
diVerence between PCO2 and tcPCO2 (kPa) at time of each
arterial blood gas measurement. Average = mean of PCO2
and tcPCO2 (kPa) at time of each arterial blood gas
measurement.
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